Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. It is one of the most studied dual-incretin peptides in contemporary metabolic research.
Vial contents: 10mg Tirzepatide lyophilized
Purity: >99% HPLC verified
Storage: -20°C lyophilized; 2–8°C reconstituted
COA: HPLC tested; COA on request
Research use only. Not for human consumption.



Reviews
There are no reviews yet.